Sign in Subscribe
Biotechnology industries

Novare Surgical Systems Announces Exclusive Distribution Agreement with Medtronic Inc.

Strategic Insights

— 1 min read

Novare Surgical Systems Inc., a pioneer in innovative devices for cardiovascular and vascular surgery, has joined forces with Medtronic Inc., the world's leading medical technology company, to expand the reach of its Enclose II Cardiac Anastomosis Assist Device. This strategic partnership will grant Medtronic's Cardiac Surgery Technologies division exclusive distribution rights for the Enclose II in key global markets. The partnership is a significant milestone for Novare, as it enables the company to tap into Medtronic's extensive marketing and sales network, thereby increasing access to cardiac surgery markets worldwide.

Key Takeaways:

  • Novare Surgical Systems Inc. has signed an exclusive distribution agreement with Medtronic Inc. for the Enclose II Cardiac Anastomosis Assist Device.
  • The agreement grants Medtronic's Cardiac Surgery Technologies division exclusive distribution rights for the Enclose II in Europe, Africa, Canada, South America, and most of Asia.
  • The partnership aims to provide customers with a unique solution for eliminating the risks associated with use of partial occlusion clamps during coronary artery bypass graft (CABG) surgery.
  • The Enclose II device is designed for use in on-pump and off-pump (beating-heart) CABG procedures and allows surgeons to create an enclosed bloodless field in the aorta without the use of a side-biting, partial occlusion clamp.
  • The Enclose II has been used in over 5000 procedures with no adverse events reported, and its development was spearheaded by renowned surgeon and inventor Thomas J. Fogarty, M.D.
  • Novare Surgical Systems Inc. has introduced the Enclose(R) Anastomotic Assist Device for use in on-pump and off-pump cardiac artery bypass surgery, and its products are sold in the United States, Europe, the Middle East, Asia, Africa, and Japan.

Statistics:

  • The Enclose II device has been used in over 5000 procedures with no adverse events reported.
  • Medtronic Inc. is the world's leading medical technology company, providing lifelong solutions for people with chronic disease.
  • Novare Surgical Systems Inc. was founded in 1999 and has introduced the Enclose(R) Anastomotic Assist Device for use in on-pump and off-pump cardiac artery bypass surgery.
  • The agreement between Novare Surgical Systems Inc. and Medtronic Inc. aims to provide a unique solution for eliminating the risks associated with partial occlusion clamps during CABG surgery.

Sources:

  • Novare Surgical Systems Inc. press release, April 22.
  • http://www.medtronic.com/
  • http://www.novaresurgical.com/
  • http://www.prnewswire.com/news-releases/novare-surgical-systems-announces-exclusive-distribution-agreement-with-medtronic-inc-10916928.html

Read more